Subscribe
Log In More

Log in via Institution
Log in via OpenAthens

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
Basket
Search More

Search for this keyword

Advanced search

Close More
Main menu

Latest content

Current issue

Archive

Authors

About
Subscribe
Log in More

Log in via Institution
Log in via OpenAthens

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
BMJ Journals More

You are viewing from: Department GEZ-LTA Erasmushogeschool

Hypertension

Review: low-dose thiazides are the most effective first-line drugs for hypertension
BMJ Evidence-Based Medicine Jan 2000, 5 (1) 10; DOI: 10.1136/ebm.5.1.10
Pravastatin lowered coronary disease risk in elderly persons with or at risk of vascular disease
BMJ Evidence-Based Medicine Jul 2003, 8 (4) 107; DOI: 10.1136/ebm.8.4.107
The combination of maternal early pregnancy characteristics and current antenatal blood pressure measurement from 28 weeks’ gestation improves the prediction of women at risk of developing pre-eclampsia
Fergus P McCarthy, Louise C Kenny

BMJ Evidence-Based Medicine Jun 2016, 21 (3) 110-111; DOI: 10.1136/ebmed-2015-110375
Review: low dose diuretics are the best first line antihypertensive treatment
BMJ Evidence-Based Medicine Jan 2004, 9 (1) 12; DOI: 10.1136/ebm.9.1.12
Laparoscopic surgery was better than an intensive non-surgical intervention for weight loss in mild to moderate obesity
BMJ Evidence-Based Medicine Oct 2006, 11 (5) 146; DOI: 10.1136/ebm.11.5.146
Home monitoring service was more effective than usual care in patients with essential hypertension
BMJ Evidence-Based Medicine Jan 2002, 7 (1) 18; DOI: 10.1136/ebm.7.1.18
Ischaemic stroke subtypes had different short term and long term functional outcomes, mortality, and recurrence rates
BMJ Evidence-Based Medicine Jan 2001, 6 (1) 26; DOI: 10.1136/ebm.6.1.26
Compared with glyburide, sitagliptin associated with incremental cost-effectiveness ratio of $169 572 per QALY and exenatide with $278 935 per QALY as second-line treatment in adult diabetics in the USA
Wendy A Davis

BMJ Evidence-Based Medicine Apr 2010, 15 (2) 40-41; DOI: 10.1136/ebm1034
Systematic review finds modest weight loss at 1 year but a lack of high-quality evidence to support the efficacy of programmes encouraging weight loss in older people
Gordon L Jensen, Pao Ying Hsiao

BMJ Evidence-Based Medicine Apr 2010, 15 (2) 41-42; DOI: 10.1136/ebm1035
Liraglutide for weight loss: more research is needed
Adam Gilden Tsai

BMJ Evidence-Based Medicine Apr 2010, 15 (2) 46-47; DOI: 10.1136/ebm1041

Pages